NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.20+0.23 (+2.89%)
Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%
NeuroPace price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
NeuroPace's price to book ratio was 36.1× on Nov 11, 2026, against 29.4× a year earlier. Over the last 5 years it ranged from 0.9× to 48.7×, with a median of 16.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 36.1× | +8.4 |
| 2025 | Dec 31, 2025 | 27.7× | −6.2 |
| 2024 | Dec 31, 2024 | 33.9× | +17.4 |
| 2023 | Dec 29, 2023 | 16.5× | +15.7 |
| 2022 | Dec 30, 2022 | 0.9× | −2.1 |
| 2021 | Dec 31, 2021 | 3.0× | – |
See a number that looks wrong?